Shares of GH Research PLC (NASDAQ:GHRS – Get Free Report) saw unusually-strong trading volume on Tuesday . Get GH Research alerts:View Our Latest Analysis on GH ResearchGH Research Price PerformanceThe firm has a market capitalization of $2.00 billion, a price-to-earnings ratio of -31.78 and a beta of 1.29. Equities research analysts expect that GH Research PLC will post -1.46 earnings per share for the current fiscal year. GH Research Company Profile(Get Free Report)GH Research Holdings Inc is a clinical-stage biotechnology company dedicated to the development of novel treatments for neuropsychiatric disorders through the application of psychedelic-inspired compounds. Featured StoriesReceive News & Ratings for GH Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GH Research and related companies with MarketBeat.com's FREE daily email newsletter.